RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:AGM our on Sedar I agree. We need a solid Q1 ideally filed by May 14 not last minute on May 17. Ideally over $4 million Since Q1 is Jan-March we won't see any Aristotle revenue so we need updates over the next 4 weeks on the roll out, other partners and a big marketing blitz. Marketing is not a couple posts on social media. I'm talking a significant spend and national exposure.
if those 2 things don't happen I can see a real chance Tripp is in trouble at the meeting
Mermer2328 wrote:
A monster Q1, will not make a difference. Aristotle,Aristotle,Aristotle. Tripp starts every interview talking about 20yrs of work to develop the best Cancer detection test on earth. That's why we all invested.. The half hearted attempt at a roll out will be his demise.. I cant currently see anything that would make me change my mind, unless we get a huge Aristotle adoption NR